During the past decade, DIAKO Ev. Diakonie Krankenhaus gGmbH conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DIAKO Ev. Diakonie Krankenhaus gGmbH" #1 sponsor was "German CLL Study Group" with 6 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Technische Universität Dresden" with 2 trials sponsored, "Christian Buske" with 1 trials sponsored and "Dominik Paul Modest" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DIAKO Ev. Diakonie Krankenhaus gGmbH" #1 collaborator was "Amgen" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator and "Celgene" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "DIAKO Ev. Diakonie Krankenhaus gGmbH" are "Chronic Lymphocytic Leukemia" (5 trials), "Lymphoma" (5 trials), "Leukemia" (3 trials), "Acute Myeloid Leukemia" (1 trials) and "Acute Myeloid Leukemia (AML)" (1 trials). Many other conditions were trialed in "DIAKO Ev. Diakonie Krankenhaus gGmbH" in a lesser frequency.

Most popular intervention types in "DIAKO Ev. Diakonie Krankenhaus gGmbH" are "Drug" (23 trials), "Biological" (9 trials), "Procedure" (4 trials), "Radiation" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (6 trials), "Rituximab" (5 trials), "doxorubicin hydrochloride" (5 trials), "prednisone" (5 trials) and "rituximab" (5 trials). Other intervention names were less common.

The vast majority of trials in "DIAKO Ev. Diakonie Krankenhaus gGmbH" are 24 trials for "All" genders.

Currently, there are NaN active trials in "DIAKO Ev. Diakonie Krankenhaus gGmbH". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in DIAKO Ev. Diakonie Krankenhaus gGmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in DIAKO Ev. Diakonie Krankenhaus gGmbH, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

DIAKO Ev. Diakonie Krankenhaus gGmbH has several departments that took part in Clinical trials: "DIAKO Ev. Diakonie-Krankenhaus Bremen GmbH; Med. Klinik II; Hämatologie und internistische Onkologie" - 4 trials